- Home
- DTIL vs OVID Comparison
DTIL vs OVID Comparison
Compare DTIL & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DTIL | OVID |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.8M | 117.5M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | DTIL | OVID |
|---|---|---|
| Price | $5.62 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $60.00 | $3.40 |
| AVG Volume (30 Days) | 180.7K | ★ 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.90 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,070,000,000.00 | $566,000.00 |
| Revenue This Year | N/A | $1,077.56 |
| Revenue Next Year | $34.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $0.24 |
| 52 Week High | $8.82 | $2.38 |
Technical Indicators
Market Signals| Indicator | DTIL | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 73.04 | 66.01 |
| Support Level | $4.50 | $1.43 |
| Resistance Level | $5.80 | $2.01 |
| Average True Range (ATR) | 0.36 | 0.16 |
| MACD | 0.16 | 0.04 |
| Stochastic Oscillator | 79.86 | 58.06 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.